IMCD Acquires Life Science Business of YCAM in South Korea

IMCD, a global distribution and formulation partner of specialty chemicals and ingredients, has agreed to acquire the personal care and pharmaceutical business of YCAM, a distributor based in South Korea.

Founded in 2010, YCAM specializes in distributing specialty ingredients for the cosmetics, personal care, and pharmaceutical markets. YCAM represents global suppliers and focuses on providing customers with formulation advice and specialty ingredients through its technical team and laboratory support, helping them stay abreast of market trends. YCAM is located in Anyang, South Korea, and generated a revenue of approximately KRW 26 billion (~ €17 million) in 2023.

"This acquisition will be an important step in expanding our footprint in our beauty and personal care market and further enriches our life science portfolio," remarked Dongjoon Lee, Managing Director of IMCD South Korea. "We are excited to welcome such a dedicated and skilled team to IMCD."

"I am convinced that YCAM’s extensive resources and knowledge can swiftly integrate into IMCD's global business model, enhancing its commercial and operational strength in South Korea's personal care and pharmaceuticals industries,” remarked Munkyum Kim, CEO of YCAM. “My team has been an invaluable asset to the company, and I believe they will have even more opportunities to develop and maximize their potential with IMCD."

The transaction is subject to closing conditions and is expected in the second quarter of 2025.

From left to right: JaeJoong Kim, Sales Director of YCAM, Fenna van Zanten,...
From left to right: JaeJoong Kim, Sales Director of YCAM, Fenna van Zanten, Director M&A and member of IMCD Group Executive Committee, Munkyum Kim, CEO of YCAM, Dongjoon Lee, Managing Director of IMCD Korea, Peter Shin, Finance Director of IMCD Korea. © IMCD

Company

Logo:

IMCD Group B.V.

Wilhelminaplein 32
3072 Rotterdam
Netherlands

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.